About Peter DeLange
Peter DeLange is a co-founder & CEO, director at Septablate.
Form D filings also name Peter DeLange as an executive officer at Aria CV.
Peter DeLange first appears on SEC filings in 2022.
Experience
This experience comes from Peter DeLange's profile and from SEC filings. For roles taken from filings, the years are when the filings name Peter DeLange in the role, so the role may have started earlier or lasted longer.
Septablate, Inc. Current
Co-founder & CEO, director
2026 – Present · Minnetonka, MN
Develops a heart treatment for patients whose anatomy excludes them from existing therapies.
VI
VTI (Vertebral Technologies, Inc.)
Director Board Of Directors
2018 – 2026
EE
Excelen, Center For Bone and Joint Research and Education
Chairman Of The Board
2010 – 2024
FO
FocusStart
Co-Founder
2013 – 2022
EN
EnteroMedics
SVP Operations & Business Development
2016 – 2017
DL
Devicix LLC
Founder & CEO
2004 – 2015
AS
Acist Medical Systems
Director of New Product Development
1997 – 2004
Key Colleagues at Startups
The people Peter DeLange works with at each company, as listed on that company's latest Form D.
Septablate, Inc. · Form D, Sep 11, 2026
TM
Thomas McPeak
Co-founder & CTO, director
Aria CV, Inc. · Form D, Aug 18, 2025
SW
Scott Ward
Director
SY
Steven Yakubov
Director
DG
Dan Gladney
Chief Executive Officer and director
GF
George Fazio
Director
DZ
Darshana Zaveri
Director
RM
Renee Masi
Director
KV
Karl Vollmers
Executive officer
JS
John Scandurra
Executive officer